You are here: Industry Insights > variant

News List

Concern over COVID-19 remains uneven in May: Poll pharmaceutical-technology
June 10, 2021
The poll asked how concerned the respondents were about the spread of coronavirus and included five options to choose from – very concerned, slightly concerned, neither concerned nor unconcerned, not very concerned, and not concerned.
Vaccinations More Urgent as Variant That Crippled India Shows Up in the U.S. drugs
June 10, 2021
The highly contagious coronavirus variant that brought India to its knees this spring now accounts for 6 percent of new cases in the United States, the Biden administration said Tuesday.
'Indian' variant of coronavirus now dominant strain in the UK pharmatimes
June 04, 2021
According to Public Health England's weekly coronavirus variant cases data, cases of the Indian or Delta (VOC-21APR-02) variant in the UK have risen by 5,472 since last week to 12,431.
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain prnasia
June 02, 2021
Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product.
BioNTech says vaccine likely to be effective against Indian variant expresspharma
May 24, 2021
BioNTech SE said yesterday that the COVID-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.
COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research expresspharma
May 24, 2021
A new study by health officials in England shows for the first time that two doses of COVID-19 vaccines are “highly effective” against the B1.617.2 variant first identified in India.
INOVIO's Pan-COVID-19 Vaccine Candidate (INO-4802) Induces Broad Immunity Against Major Viral Variants in Preclinical Studies prnewswire
May 13, 2021
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that its next-generation Pan-COVID-19 vaccine candidate ...
COVID strain identified in India is ‘variant of concern’: WHO expresspharma
May 11, 2021
There is some available information to suggest increased transmissibility of B-1617, said Dr Maria Van Kerkhove, COVID-19 Technical Lead at the World Health Organisation (WHO).
Inovio’s Covid-19 vaccine induces immune responses against variants pharmaceutical-technology
April 19, 2021
Inovio has reported that results from a study of its DNA Covid-19 vaccine candidate INO-4800 showed it induced a robust T cell response in humans against all spike protein variants of concern.
B.1.1.7. variant more transmissible, does not increase severity, Lancet studies suggest worldpharmanews
April 14, 2021
Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected ...

Previous page 1 2 3 4 5 6 7 Next page